Western Pacific Wealth Management’s AbbVie ABBV Stock Holding History

Western Pacific Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$180K	Hold	827	–	–	0.18%	63
2025 Q4	$189K	Hold	827	–	–	0.18%	63
2025 Q3	$191K	Hold	827	–	–	0.19%	70
2025 Q2	$154K	Sell	827 -177	-18%	-$32.9K	0.15%	82
2025 Q1	$210K	Hold	1,004	–	–	0.19%	60
2024 Q4	$178K	Buy	1,004 +31	+3%	+$5.7K	0.14%	73
2024 Q3	$192K	Hold	973	–	–	0.13%	61
2024 Q2	$167K	Hold	973	–	–	0.13%	60
2024 Q1	$177K	Hold	973	–	–	0.13%	60
2023 Q4	$151K	Hold	973	–	–	0.11%	63
2023 Q3	$145K	Hold	973	–	–	0.12%	57
2023 Q2	$131K	Sell	973 -163	-14%	-$23.9K	0.1%	61
2023 Q1	$181K	Buy	1,136 +100	+10%	+$15.3K	0.14%	43
2022 Q4	$167K	Buy	1,036 +31	+3%	+$4.75K	0.14%	43
2022 Q3	$134K	Buy	1,005 +583	+138%	+$83.7K	0.13%	38
2022 Q2	$64K	Hold	422	–	–	0.06%	62
2022 Q1	$68K	Hold	422	–	–	0.05%	71
2021 Q4	$57K	Buy	+422	New	+$49.8K	0.04%	99

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Western Pacific Wealth Management's ABBV Position: Q1 2026 in Review

Western Pacific Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 827 shares worth $180K. The position accounts for 0.18% of the portfolio, ranked #63.

Western Pacific Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $210K in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Western Pacific Wealth Management held 827 shares of AbbVie worth $180K as of Q1 2026.
Western Pacific Wealth Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.18% of Western Pacific Wealth Management's portfolio in Q1 2026, its #63 holding.
Western Pacific Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Western Pacific Wealth Management's AbbVie position peaked at $210K in Q1 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Western Pacific Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.